trofosfamide has been researched along with Cancer of Lung in 11 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 2 (18.18) | 18.7374 |
| 1990's | 1 (9.09) | 18.2507 |
| 2000's | 7 (63.64) | 29.6817 |
| 2010's | 1 (9.09) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Reißig, A; Walther, M | 1 |
| Finckenstein, FG; Graf, N; Gruhn, B; Hasan, C; Hero, B; Klingebiel, T; Koscielniak, E; Kremens, B; Laws, HJ; Niemeyer, C; Schulz, A; Selle, B; Wawer, A; Zintl, F | 1 |
| Al-Batran, SE; Atmaca, A; Bert, F; Frisch, C; Jäger, D; Jäger, E; Knuth, A; Neumann, A; Orth, J | 1 |
| Bela, C; Engels, C; Klink, T; Stölting, S; Wagner, T | 1 |
| Bela, C; Broll, R; Klink, T; Peters, SO; Stoelting, S; Wagner, T | 1 |
| Debruyne, PR; Demey, W; Dumez, H; Gillis, L; Schöffski, P; Sciot, R | 1 |
| Andritzky, B; Anige, M; Bokemeyer, C; Brandl, S; Burkholder, I; Edler, L; Görn, M; Habermann, CR; Hossfeld, DK; Laack, E; Schuch, G; Thöm, I | 1 |
| Kokron, O | 1 |
| Eberhardt, W; Harstrick, A; Klaassen, U; Korn, MW; Müller, C; Seeber, S; Strumberg, D; Wilke, H | 1 |
| Halme, M; Isokangas, OP; Joensuu, H; Mäntylä, M; Mattson, K; Pekonen, M; Pyrhönen, S; Ruotsalainen, T; Sarna, S | 1 |
| Budzyński, W; Kinas, R; Kuśnierczyk, H; Misiura, K; Paprocka, M; Radzikowski, C; Rak, J; Stec, W | 1 |
4 trial(s) available for trofosfamide and Cancer of Lung
| Article | Year |
|---|---|
Dose escalation study for defining the maximum tolerated dose of continuous oral trofosfamide in pretreated patients with metastatic lung cancer.
Topics: Administration, Oral; Aged; Aged, 80 and over; Antineoplastic Agents; Carcinoma; Carcinoma, Non-Small-Cell Lung; Carcinoma, Small Cell; Cohort Studies; Cyclophosphamide; Dose-Response Relationship, Drug; Drug Administration Schedule; Female; Hematologic Diseases; Humans; Lung Neoplasms; Male; Maximum Tolerated Dose; Middle Aged; Risk Assessment; Risk Factors | 2004 |
A pilot study of docetaxel and trofosfamide as second-line 'metronomic' chemotherapy in the treatment of metastatic non-small cell lung cancer (NSCLC).
Topics: Adult; Aged; Angiogenesis Inhibitors; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Non-Small-Cell Lung; Clinical Trials as Topic; Cyclophosphamide; Docetaxel; Drug Administration Schedule; Humans; Lung Neoplasms; Middle Aged; Pilot Projects; Practice Patterns, Physicians'; Survival Analysis; Survival Rate; Taxoids; Treatment Outcome | 2008 |
Phase II trial of continuous oral trofosfamide in patients with advanced colorectal cancer refractory to 5-fluorouracil.
Topics: Adult; Aged; Antimetabolites, Antineoplastic; Antineoplastic Agents, Alkylating; Colorectal Neoplasms; Cyclophosphamide; Drug Resistance, Neoplasm; Female; Fluorouracil; Follow-Up Studies; Humans; Liver Neoplasms; Lung Neoplasms; Male; Middle Aged; Neoplasm Staging | 1997 |
Interferon-alpha and 13-cis-retinoic acid as maintenance therapy after high-dose combination chemotherapy with growth factor support for small cell lung cancer--a feasibility study.
Topics: Administration, Oral; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Carcinoma, Small Cell; Combined Modality Therapy; Cyclophosphamide; Disease-Free Survival; Drug Administration Schedule; Etoposide; Feasibility Studies; Female; Finland; Humans; Ifosfamide; Injections, Subcutaneous; Interferon-alpha; Isotretinoin; Lung Neoplasms; Male; Middle Aged | 2000 |
7 other study(ies) available for trofosfamide and Cancer of Lung
| Article | Year |
|---|---|
Old wine in new pipes? Treatment of advanced non-small cell lung cancer with trofosfamide.
Topics: Antineoplastic Agents, Alkylating; Carcinoma, Non-Small-Cell Lung; Cyclophosphamide; Female; Humans; Lung Neoplasms; Male; Middle Aged; Retrospective Studies; Survival Rate; Treatment Outcome | 2013 |
High-dose chemotherapy with autologous stem cell rescue in children with nephroblastoma.
Topics: Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Child; Child, Preschool; Combined Modality Therapy; Cyclophosphamide; Disease-Free Survival; Etoposide; Female; Germany; Hematologic Diseases; Humans; Ifosfamide; Infant; Kidney Diseases; Kidney Neoplasms; Life Tables; Lung Neoplasms; Male; Melphalan; Peripheral Blood Stem Cell Transplantation; Prognosis; Stomatitis; Survival Analysis; Thiotepa; Transplantation, Autologous; Wilms Tumor | 2002 |
Metronomic scheduling of trofosfamide chemotherapy in human NSCLC xenografts highly increases therapeutic efficacy compared to conventional scheduling by inhibition of angiogenesis.
Topics: Animals; Antineoplastic Agents, Alkylating; Carcinoma, Non-Small-Cell Lung; Cyclophosphamide; Drug Administration Schedule; Humans; Lung Neoplasms; Mice; Mice, Nude; Neovascularization, Pathologic; Transplantation, Heterologous; Tumor Cells, Cultured | 2004 |
Metronomic trofosfamide inhibits progression of human lung cancer xenografts by exerting anti-angiogenic effects.
Topics: Angiogenesis Inhibitors; Animals; Antineoplastic Agents, Alkylating; Apoptosis; Carcinoma, Non-Small-Cell Lung; Cyclophosphamide; Drug Administration Schedule; Endothelial Cells; Female; Humans; Inhibitory Concentration 50; Lung Neoplasms; Mice; Mice, Nude; Time Factors; Tumor Cells, Cultured; Xenograft Model Antitumor Assays | 2006 |
Recurrent low- to intermediate-grade chondrosarcoma of the thumb with lung metastases: an objective response to trofosfamide.
Topics: Aged; Antineoplastic Agents, Alkylating; Bone Neoplasms; Carpometacarpal Joints; Chemotherapy, Adjuvant; Chondrosarcoma; Combined Modality Therapy; Cyclophosphamide; Female; Follow-Up Studies; Humans; Lung Neoplasms; Neoplasm Recurrence, Local; Remission Induction; Thumb; Tomography, X-Ray Computed | 2007 |
[Polychemotherapy for advanced epidermoid cell lung cancer (author's transl)].
Topics: Aged; Carcinoma, Squamous Cell; Cyclophosphamide; Doxorubicin; Drug Therapy, Combination; Evaluation Studies as Topic; Female; Humans; Lung Neoplasms; Male; Methotrexate; Middle Aged; Neoplasm Staging; Vincristine | 1982 |
Antitumor activity of optical isomers of cyclophosphamide, ifosfamide and trofosfamide as compared to clinically used racemates.
Topics: Animals; Antineoplastic Agents; Cyclophosphamide; Drug Evaluation, Preclinical; Female; Ifosfamide; Lethal Dose 50; Leukemia, Experimental; Lung Neoplasms; Male; Mammary Neoplasms, Experimental; Mice; Mice, Inbred Strains; Neoplasms, Experimental; Plasmacytoma; Stereoisomerism | 1986 |